# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Canaccord Genuity analyst Kingsley Crane maintains UiPath (NYSE:PATH) with a Buy and lowers the price target from $30 to $19.
On Thursday, Cathie Wood-led Ark Invest made notable adjustments to its portfolio, including a significant sell-off of Robinhoo...
Barclays analyst Raimo Lenschow maintains UiPath (NYSE:PATH) with a Equal-Weight and lowers the price target from $25 to $16.
JP Morgan analyst Mark Murphy maintains UiPath (NYSE:PATH) with a Overweight and lowers the price target from $28 to $19.
DA Davidson analyst Gil Luria maintains UiPath (NYSE:PATH) with a Neutral and lowers the price target from $24 to $13.